General Information of This Drug (ID: DMXBZ1D)

Drug Name
Kinetin   DMXBZ1D
Synonyms Kinerase (TN)
Indication
Disease Entry ICD 11 Status REF
Skin photodamage EJ40 Approved [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

3 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
Kinetin + Ruxolitinib DCSYD1I Ruxolitinib Hodgkin lymphoma (Cell Line: L-1236) [2]
Kinetin + Panobinostat DC4R9UI Panobinostat Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [2]
Kinetin + Idarubicin DCGZ73V Idarubicin Glioblastoma? (Cell Line: T98G) [2]
------------------------------------------------------------------------------------

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.